Clinical Trial Update: Cell Therapy for Immunomodulation in Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of a cell therapy for immunomodulation in kidney transplantation, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Thomas Wekerle | Conditions: Kidney Transplantation | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING